We are live on ! Find out more
TXMD icon

TherapeuticsMD

131 hedge funds and large institutions have $44.1M invested in TherapeuticsMD in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 50 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more call options, than puts

Call options by funds: $438K | Put options by funds: $208K

2.24% less ownership

Funds ownership: 31.42% → 29.18% (-2.2%)

11% less funds holding

Funds holding: 148 → 131 (-17)

38% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 50

54% less capital inflows, than outflows

Capital inflows: $4.68M | Capital outflows: $10.3M

77% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 31

Holders
131
Holders Change
-17
Holders Change %
-11.49%
% of All Funds
2.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
31
Reduced
50
Closed
31
Calls
$438​K
Puts
$208​K
Net Calls
+$230​K
Net Calls Change
-⁠$307​K

TXMD Hedge Fund Activity: Q4 2021 in Review

131 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q4 2021, worth a combined $44.1M — down 55% from $98.2M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of TXMD and 7 opened new positions — a net loss of 24 holders — while 50 trimmed existing stakes and 31 added.

The largest buyer was Vanguard Group, adding an estimated $730K. The largest seller was Sanders Morris Harris, cutting an estimated $1.83M.

  • 131 institutional investors held TherapeuticsMD (TXMD) as of Q4 2021, down from 148 in Q3 2021.
  • Funds reported $44.1M of TherapeuticsMD stock for Q4 2021, down 55% quarter-over-quarter.
  • 7 funds opened new TherapeuticsMD positions in Q4 2021 and 31 closed out, a net change of -24 holders.
  • The largest TherapeuticsMD buyer in Q4 2021 was Vanguard Group, an estimated $730K added.
  • The largest TherapeuticsMD seller in Q4 2021 was Sanders Morris Harris, an estimated $1.83M sold.

Based on aggregated 13F filings for Q4 2021.